Endencia, Nilda N.
HRN: 23-30-55 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2023
CEFTRIAXONE 1G (VIAL)
07/12/2023
07/18/2023
IV
2g
OD
CAP-MR
Waiting Final Action